SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-056777
Filing Date
2023-11-28
Accepted
2023-11-28 16:16:54
Documents
1
Period of Report
2023-11-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4935
  Complete submission text file 0001209191-23-056777.txt   6408
Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Issuer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SANGAMO THERAPEUTICS, INC. 7000 MARINA BOULEVARD BRISBANE CA 94005
Business Address
Dubois-Stringfellow Nathalie (Reporting) CIK: 0001947007 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30171 | Film No.: 231446671